What is the impact of utilization management tools, including prior authorization, step therapy, and quantity limits, on patient clinical outcomes?

Evidence is limited or indirect but suggests utilization management tools like prior authorization, step therapy, and quantity limits can adversely impact patient clinical outcomes, primarily through delays in treatment and increased medication abandonment.